APA (7th ed.) Citation

Albers, F. C., Papi, A., Taillé, C., Bratton, D. J., Bradford, E. S., Yancey, S. W., & Kwon, N. (2019). Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: Meta-analysis of MENSA and MUSCA. Respiratory Research, 20(1), N.PAG. https://doi.org/10.1186/s12931-019-1134-7

Chicago Style (17th ed.) Citation

Albers, Frank C., Alberto Papi, Camille Taillé, Daniel J. Bratton, Eric S. Bradford, Steven W. Yancey, and Namhee Kwon. "Mepolizumab Reduces Exacerbations in Patients with Severe Eosinophilic Asthma, Irrespective of Body Weight/body Mass Index: Meta-analysis of MENSA and MUSCA." Respiratory Research 20, no. 1 (2019): N.PAG. https://doi.org/10.1186/s12931-019-1134-7.

MLA (9th ed.) Citation

Albers, Frank C., et al. "Mepolizumab Reduces Exacerbations in Patients with Severe Eosinophilic Asthma, Irrespective of Body Weight/body Mass Index: Meta-analysis of MENSA and MUSCA." Respiratory Research, vol. 20, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s12931-019-1134-7.